Copyright Reports & Markets. All rights reserved.

Global and Japan Parkinson's Disease Therapeutics Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Parkinson's Disease Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
    • 1.2.2 Medications Therapeutics
    • 1.2.3 Medical Devices Therapeutics
  • 1.3 Market by Application
    • 1.3.1 Global Parkinson's Disease Therapeutics Market Share by Application: 2020 VS 2026
    • 1.3.2 Under 40 Years Old
    • 1.3.3 40-65 Years Old
    • 1.3.4 Above 65 Years Old
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Parkinson's Disease Therapeutics Market Perspective (2015-2026)
  • 2.2 Global Parkinson's Disease Therapeutics Growth Trends by Regions
    • 2.2.1 Parkinson's Disease Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Parkinson's Disease Therapeutics Historic Market Share by Regions (2015-2020)
    • 2.2.3 Parkinson's Disease Therapeutics Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Parkinson's Disease Therapeutics Players by Market Size
    • 3.1.1 Global Top Parkinson's Disease Therapeutics Players by Revenue (2015-2020)
    • 3.1.2 Global Parkinson's Disease Therapeutics Revenue Market Share by Players (2015-2020)
  • 3.2 Global Parkinson's Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Parkinson's Disease Therapeutics Revenue
  • 3.4 Global Parkinson's Disease Therapeutics Market Concentration Ratio
    • 3.4.1 Global Parkinson's Disease Therapeutics Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Parkinson's Disease Therapeutics Revenue in 2019
  • 3.5 Key Players Parkinson's Disease Therapeutics Area Served
  • 3.6 Key Players Parkinson's Disease Therapeutics Product Solution and Service
  • 3.7 Date of Enter into Parkinson's Disease Therapeutics Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Parkinson's Disease Therapeutics Breakdown Data by Type (2015-2026)

  • 4.1 Global Parkinson's Disease Therapeutics Historic Market Size by Type (2015-2020)
  • 4.2 Global Parkinson's Disease Therapeutics Forecasted Market Size by Type (2021-2026)

5 Parkinson's Disease Therapeutics Breakdown Data by Application (2015-2026)

  • 5.1 Global Parkinson's Disease Therapeutics Historic Market Size by Application (2015-2020)
  • 5.2 Global Parkinson's Disease Therapeutics Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Parkinson's Disease Therapeutics Market Size (2015-2026)
  • 6.2 North America Parkinson's Disease Therapeutics Market Size by Type (2015-2020)
  • 6.3 North America Parkinson's Disease Therapeutics Market Size by Application (2015-2020)
  • 6.4 North America Parkinson's Disease Therapeutics Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Parkinson's Disease Therapeutics Market Size (2015-2026)
  • 7.2 Europe Parkinson's Disease Therapeutics Market Size by Type (2015-2020)
  • 7.3 Europe Parkinson's Disease Therapeutics Market Size by Application (2015-2020)
  • 7.4 Europe Parkinson's Disease Therapeutics Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic
    • 7.4.7 Rest of Europe

8 China

  • 8.1 China Parkinson's Disease Therapeutics Market Size (2015-2026)
  • 8.2 China Parkinson's Disease Therapeutics Market Size by Type (2015-2020)
  • 8.3 China Parkinson's Disease Therapeutics Market Size by Application (2015-2020)
  • 8.4 China Parkinson's Disease Therapeutics Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia
    • 8.4.7 Rest of Asia-Pacific

9 Japan

  • 9.1 Japan Parkinson's Disease Therapeutics Market Size (2015-2026)
  • 9.2 Japan Parkinson's Disease Therapeutics Market Size by Type (2015-2020)
  • 9.3 Japan Parkinson's Disease Therapeutics Market Size by Application (2015-2020)
  • 9.4 Japan Parkinson's Disease Therapeutics Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Southeast Asia

  • 10.1 Southeast Asia Parkinson's Disease Therapeutics Market Size (2015-2026)
  • 10.2 Southeast Asia Parkinson's Disease Therapeutics Market Size by Type (2015-2020)
  • 10.3 Southeast Asia Parkinson's Disease Therapeutics Market Size by Application (2015-2020)
  • 10.4 Southeast Asia Parkinson's Disease Therapeutics Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE
    • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

  • 11.1 GSK
    • 11.1.1 GSK Company Details
    • 11.1.2 GSK Business Overview
    • 11.1.3 GSK Parkinson's Disease Therapeutics Introduction
    • 11.1.4 GSK Revenue in Parkinson's Disease Therapeutics Business (2015-2020))
    • 11.1.5 GSK Recent Development
  • 11.2 Novartis
    • 11.2.1 Novartis Company Details
    • 11.2.2 Novartis Business Overview
    • 11.2.3 Novartis Parkinson's Disease Therapeutics Introduction
    • 11.2.4 Novartis Revenue in Parkinson's Disease Therapeutics Business (2015-2020)
    • 11.2.5 Novartis Recent Development
  • 11.3 Boehringer Ingelheim
    • 11.3.1 Boehringer Ingelheim Company Details
    • 11.3.2 Boehringer Ingelheim Business Overview
    • 11.3.3 Boehringer Ingelheim Parkinson's Disease Therapeutics Introduction
    • 11.3.4 Boehringer Ingelheim Revenue in Parkinson's Disease Therapeutics Business (2015-2020)
    • 11.3.5 Boehringer Ingelheim Recent Development
  • 11.4 Teva Pharmaceutical
    • 11.4.1 Teva Pharmaceutical Company Details
    • 11.4.2 Teva Pharmaceutical Business Overview
    • 11.4.3 Teva Pharmaceutical Parkinson's Disease Therapeutics Introduction
    • 11.4.4 Teva Pharmaceutical Revenue in Parkinson's Disease Therapeutics Business (2015-2020)
    • 11.4.5 Teva Pharmaceutical Recent Development
  • 11.5 Abbvie
    • 11.5.1 Abbvie Company Details
    • 11.5.2 Abbvie Business Overview
    • 11.5.3 Abbvie Parkinson's Disease Therapeutics Introduction
    • 11.5.4 Abbvie Revenue in Parkinson's Disease Therapeutics Business (2015-2020)
    • 11.5.5 Abbvie Recent Development
  • 11.6 Merck
    • 11.6.1 Merck Company Details
    • 11.6.2 Merck Business Overview
    • 11.6.3 Merck Parkinson's Disease Therapeutics Introduction
    • 11.6.4 Merck Revenue in Parkinson's Disease Therapeutics Business (2015-2020)
    • 11.6.5 Merck Recent Development
  • 11.7 Akorn
    • 11.7.1 Akorn Company Details
    • 11.7.2 Akorn Business Overview
    • 11.7.3 Akorn Parkinson's Disease Therapeutics Introduction
    • 11.7.4 Akorn Revenue in Parkinson's Disease Therapeutics Business (2015-2020)
    • 11.7.5 Akorn Recent Development
  • 11.8 Kyowa Hakko Kirin Pharma
    • 11.8.1 Kyowa Hakko Kirin Pharma Company Details
    • 11.8.2 Kyowa Hakko Kirin Pharma Business Overview
    • 11.8.3 Kyowa Hakko Kirin Pharma Parkinson's Disease Therapeutics Introduction
    • 11.8.4 Kyowa Hakko Kirin Pharma Revenue in Parkinson's Disease Therapeutics Business (2015-2020)
    • 11.8.5 Kyowa Hakko Kirin Pharma Recent Development
  • 11.9 Astellas Pharma
    • 11.9.1 Astellas Pharma Company Details
    • 11.9.2 Astellas Pharma Business Overview
    • 11.9.3 Astellas Pharma Parkinson's Disease Therapeutics Introduction
    • 11.9.4 Astellas Pharma Revenue in Parkinson's Disease Therapeutics Business (2015-2020)
    • 11.9.5 Astellas Pharma Recent Development
  • 11.10 Desitin Arzneimittel
    • 11.10.1 Desitin Arzneimittel Company Details
    • 11.10.2 Desitin Arzneimittel Business Overview
    • 11.10.3 Desitin Arzneimittel Parkinson's Disease Therapeutics Introduction
    • 11.10.4 Desitin Arzneimittel Revenue in Parkinson's Disease Therapeutics Business (2015-2020)
    • 11.10.5 Desitin Arzneimittel Recent Development
  • 11.11 Endo Pharmaceuticals
    • 10.11.1 Endo Pharmaceuticals Company Details
    • 10.11.2 Endo Pharmaceuticals Business Overview
    • 10.11.3 Endo Pharmaceuticals Parkinson's Disease Therapeutics Introduction
    • 10.11.4 Endo Pharmaceuticals Revenue in Parkinson's Disease Therapeutics Business (2015-2020)
    • 10.11.5 Endo Pharmaceuticals Recent Development
  • 11.12 F.Hoffmann-La Roche
    • 10.12.1 F.Hoffmann-La Roche Company Details
    • 10.12.2 F.Hoffmann-La Roche Business Overview
    • 10.12.3 F.Hoffmann-La Roche Parkinson's Disease Therapeutics Introduction
    • 10.12.4 F.Hoffmann-La Roche Revenue in Parkinson's Disease Therapeutics Business (2015-2020)
    • 10.12.5 F.Hoffmann-La Roche Recent Development
  • 11.13 H.Lundbeck
    • 10.13.1 H.Lundbeck Company Details
    • 10.13.2 H.Lundbeck Business Overview
    • 10.13.3 H.Lundbeck Parkinson's Disease Therapeutics Introduction
    • 10.13.4 H.Lundbeck Revenue in Parkinson's Disease Therapeutics Business (2015-2020)
    • 10.13.5 H.Lundbeck Recent Development
  • 11.14 Valeant
    • 10.14.1 Valeant Company Details
    • 10.14.2 Valeant Business Overview
    • 10.14.3 Valeant Parkinson's Disease Therapeutics Introduction
    • 10.14.4 Valeant Revenue in Parkinson's Disease Therapeutics Business (2015-2020)
    • 10.14.5 Valeant Recent Development
  • 11.15 Apokyn
    • 10.15.1 Apokyn Company Details
    • 10.15.2 Apokyn Business Overview
    • 10.15.3 Apokyn Parkinson's Disease Therapeutics Introduction
    • 10.15.4 Apokyn Revenue in Parkinson's Disease Therapeutics Business (2015-2020)
    • 10.15.5 Apokyn Recent Development
  • 11.16 Orion
    • 10.16.1 Orion Company Details
    • 10.16.2 Orion Business Overview
    • 10.16.3 Orion Parkinson's Disease Therapeutics Introduction
    • 10.16.4 Orion Revenue in Parkinson's Disease Therapeutics Business (2015-2020)
    • 10.16.5 Orion Recent Development
  • 11.17 Stada Arzneimittel
    • 10.17.1 Stada Arzneimittel Company Details
    • 10.17.2 Stada Arzneimittel Business Overview
    • 10.17.3 Stada Arzneimittel Parkinson's Disease Therapeutics Introduction
    • 10.17.4 Stada Arzneimittel Revenue in Parkinson's Disease Therapeutics Business (2015-2020)
    • 10.17.5 Stada Arzneimittel Recent Development
  • 11.18 US WorldMeds
    • 10.18.1 US WorldMeds Company Details
    • 10.18.2 US WorldMeds Business Overview
    • 10.18.3 US WorldMeds Parkinson's Disease Therapeutics Introduction
    • 10.18.4 US WorldMeds Revenue in Parkinson's Disease Therapeutics Business (2015-2020)
    • 10.18.5 US WorldMeds Recent Development
  • 11.19 Bausch Health
    • 10.19.1 Bausch Health Company Details
    • 10.19.2 Bausch Health Business Overview
    • 10.19.3 Bausch Health Parkinson's Disease Therapeutics Introduction
    • 10.19.4 Bausch Health Revenue in Parkinson's Disease Therapeutics Business (2015-2020)
    • 10.19.5 Bausch Health Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global Parkinson's Disease Therapeutics Scope and Market Size
    Parkinson's Disease Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Parkinson's Disease Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Market segment by Type, the product can be split into
    Medications Therapeutics
    Medical Devices Therapeutics

    Market segment by Application, split into
    Under 40 Years Old
    40-65 Years Old
    Above 65 Years Old

    Based on regional and country-level analysis, the Parkinson's Disease Therapeutics market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia-Pacific
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of Middle East & Africa

    In the competitive analysis section of the report, leading as well as prominent players of the global Parkinson's Disease Therapeutics market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    GSK
    Novartis
    Boehringer Ingelheim
    Teva Pharmaceutical
    Abbvie
    Merck
    Akorn
    Kyowa Hakko Kirin Pharma
    Astellas Pharma
    Desitin Arzneimittel
    Endo Pharmaceuticals
    F.Hoffmann-La Roche
    H.Lundbeck
    Valeant
    Apokyn
    Orion
    Stada Arzneimittel
    US WorldMeds
    Bausch Health

    Buy now